These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33300826)

  • 21. Admission Serum Calcium Levels Improve the GRACE Risk Score Prediction of Hospital Mortality in Patients With Acute Coronary Syndrome.
    Yan SD; Liu XJ; Peng Y; Xia TL; Liu W; Tsauo JY; Xu YN; Chai H; Huang FY; Chen M; Huang DJ
    Clin Cardiol; 2016 Sep; 39(9):516-23. PubMed ID: 27279131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
    Klingenberg R; Aghlmandi S; Räber L; Akhmedov A; Gencer B; Carballo D; Nanchen D; Bucher HC; Rodondi N; Mach F; Windecker S; Landmesser U; von Eckardstein A; Hamm CW; Lüscher TF; Matter CM
    J Am Heart Assoc; 2021 Oct; 10(20):e020488. PubMed ID: 34622666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Bobadilla M; Reimann I; Guba-Quint A; Marquardt I; Bethmann K; Korf-Klingebiel M; Kempf T; Lichtinghagen R; Katus HA; Giannitsis E; Wollert KC
    Clin Chem; 2013 Oct; 59(10):1497-505. PubMed ID: 23818444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
    Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
    Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricemia as a prognostic factor after acute coronary syndrome.
    Lopez-Pineda A; Cordero A; Carratala-Munuera C; Orozco-Beltran D; Quesada JA; Bertomeu-Gonzalez V; Gil-Guillen VF; Bertomeu-Martinez V
    Atherosclerosis; 2018 Feb; 269():229-235. PubMed ID: 29407598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
    Helanova K; Littnerova S; Kubena P; Ganovska E; Pavlusova M; Kubkova L; Jarkovsky J; Pavkova Goldbergova M; Lipkova J; Gottwaldova J; Kala P; Toman O; Dastych M; Spinar J; Parenica J
    BMJ Open; 2015 Oct; 5(10):e006872. PubMed ID: 26438132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating glomerular filtration rate in acute coronary syndromes: Different equations, different mortality risk prediction.
    Almeida I; Caetano F; Barra S; Madeira M; Mota P; Leitão-Marques A
    Eur Heart J Acute Cardiovasc Care; 2016 Jun; 5(3):223-30. PubMed ID: 25740222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    He PC; Duan CY; Liu YH; Wei XB; Lin SG
    BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery.
    Redfors B; He CH; Palmerini T; Caixeta A; Giustino G; Ayele GM; Kirtane AJ; Mehran R; Stone GW; Généreux P
    J Invasive Cardiol; 2017 Feb; 29(2):42-49. PubMed ID: 27974670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.
    Timóteo AT; Papoila AL; Rio P; Miranda F; Ferreira ML; Ferreira RC
    Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):257-63. PubMed ID: 24687188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting.
    Soto K; Papoila AL; Coelho S; Bennett M; Ma Q; Rodrigues B; Fidalgo P; Frade F; Devarajan P
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2053-63. PubMed ID: 24009223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.
    Jakimov T; Mrdović I; Filipović B; Zdravković M; Djoković A; Hinić S; Milić N; Filipović B
    Croat Med J; 2017 Dec; 58(6):406-415. PubMed ID: 29308832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease.
    Maiolino G; Rossitto G; Pedon L; Cesari M; Frigo AC; Azzolini M; Plebani M; Rossi GP
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):725-32. PubMed ID: 25614283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction.
    Lu PJ; Gong XW; Liu Y; Tian FS; Zhang WJ; Liu YW; Yao ZH; Wang JX; Han P; Yang YN; Cui Z; Gao J
    Am J Cardiol; 2021 Feb; 140():13-19. PubMed ID: 33159905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
    Clin Cardiol; 2016 Sep; 39(9):507-15. PubMed ID: 27249221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-Hour Post-Load Plasma Glucose, a Biomarker to Improve the GRACE Score in Patients without Known Diabetes.
    Chattopadhyay S; George A; John J; Sathyapalan T
    Cardiology; 2020; 145(9):553-561. PubMed ID: 32784310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.